Dapahenz 10 Tablet
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Dapahenz 10 Tablet
Dapacarb 10mg tablets are indicated as monotherapy or in combination regimens to manage type 2 diabetes. They effectively regulate elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular health. Dapacarb 10mg can be administered with or without food, consistently at the same time each day, as prescribed by your physician. Discontinuation should only occur under medical supervision; otherwise, hyperglycemia and subsequent complications such as nephropathy and retinopathy may arise. This medication forms part of a comprehensive treatment plan encompassing dietary adjustments, physical activity, and weight management, as directed by your doctor. Common adverse events include vulvovaginal candidiasis, nasopharyngitis, and urinary tract infections; dehydration may also occur, necessitating increased fluid intake. Practicing good hygiene can reduce the risk of genital fungal infections. Prior to commencing treatment, disclose any pre-existing renal or hepatic impairment, urinary tract infections, or diuretic use. Pregnant or lactating individuals should seek medical counsel. Limit alcohol consumption to minimize potential side effects. Regular blood glucose monitoring is crucial during treatment.
Primary Ingredients of Dapahenz 10 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Dapahenz 10 Tablet
Managing type 2 diabetes
Major Benefits of Dapahenz 10 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapahenz 10 Tablet can be administered with or without food, though consistent timing is recommended.
Common Side effects of Dapahenz 10 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapahenz 10 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapahenz 10 Tablet can be administered with or without food, though consistent timing is recommended.
How Dapahenz 10 Tablet works:
Xigduo XR 10 mg tablets are used to manage type 2 diabetes. Their mechanism involves facilitating the excretion of surplus glucose via the urinary tract.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapahenz 10 Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dapahenz 10 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dapahenz 10 Tablet while breastfeeding is likely inadvisable. Available data from humans indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dapahenz 10 Tablet is likely inadvisable for individuals with kidney impairment and should be avoided. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapahenz 10 mg tablets are suitable for patients with hepatic impairment. No alteration in Dapahenz 10 mg tablet dosage is necessary.
What if you forget to take Dapahenz 10 Tablet :
Should you forget a Dapahenz 10 Tablet dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapahenz 10 Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |



